News Prilenia eyes 2025 launch for Huntington’s drug pridopidine Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine in the EU, despite mixed results in a phase 3 trial.
Patients Conference report: Reuters Pharma Europe In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts edito
Digital Fixing clinical trial data management It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.